Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Morning LANTUS v. Intermediate-acting Insulin 2x/Day as Basal Insulin in a Multiple Daily Inj. w/ Humalog in Adolescents w/ Type 1 Diabetes Mellitus: an Active-controlled, Open, Randomized, Gender-stratified, Two-arm, Parallel-group Study

NCT00046501 is registered in ClinicalTrials.gov with Sanofi as lead sponsor.

NCT NCT00046501
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT00046501 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Morning LANTUS v. Intermediate-acting Insulin 2x/Day as Basal Insulin in a Multiple Daily Inj. w/ Humalog in Adolescents w/ Type 1 Diabetes Mellitus: an Active-controlled, Open, Randomized, Gender-stratified, Two-arm, Parallel-group Study
Lead sponsor
Sanofi
Phase
Phase 3
Overall status
Completed
Start date
November 30, 2002
Completion date
Not reported
Enrollment
250
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

diabetes mellitus